GlaxoSmithKline PLC

Pharmaceuticals
United Kingdom
Earnings Per Share Growth (%)203.88%
Cost of Goods Sold (US$ Millions)$13,120
Current Liabilities (US$ Millions)$19,883
Total Assets (US$ Millions)$24,581
Long Term Debt$22,709
Return on Equity197.56%
Revenue (US$ Millions)$35,453
Total Company Assets$79,204
Revenue Growth (%)3.99%
Net Income (US$ Millions)$12,481
Earnings Per Share (US$)$203.88
Total Equity (US$ Millions)$7,579
Profit Margin (%)35.20%
Debt To Equity Ratio (%)3.00%
Inventory Turnover$6,989